TRAIL alone or combination with conventional chemotherapeutics or biologics has been evaluated for treatment of advanced cancer including lymphoma, colorectal cancer and non-small cell lung cancer [39–41]. The gene discussed is TNFSF10; the disease is non-small cell lung carcinoma.